These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2049236)

  • 1. Pharmacokinetics of metoclopramide in patients with liver cirrhosis.
    Magueur E; Hagege H; Attali P; Singlas E; Etienne JP; Taburet AM
    Br J Clin Pharmacol; 1991 Feb; 31(2):185-7. PubMed ID: 2049236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of intravenous metoclopramide in patients with hepatic cirrhosis.
    Albani F; Tamè MR; De Palma R; Bernardi M
    Eur J Clin Pharmacol; 1991; 40(4):423-5. PubMed ID: 2050180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of intravenous and oral pentoxifylline in healthy volunteers and in cirrhotic patients.
    Rames A; Poirier JM; LeCoz F; Midavaine M; Lecocq B; Grange JD; Poupon R; Cheymol G; Jaillon P
    Clin Pharmacol Ther; 1990 Mar; 47(3):354-9. PubMed ID: 2178853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flumazenil disposition and elimination in cirrhosis.
    Janssen U; Walker S; Maier K; von Gaisberg U; Klotz U
    Clin Pharmacol Ther; 1989 Sep; 46(3):317-23. PubMed ID: 2505960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Famotidine pharmacokinetics following oral and intravenous administration in patients with liver disease: results of a preliminary study.
    Morgan MY; Stambuk D
    Postgrad Med J; 1986; 62 Suppl 2():29-37. PubMed ID: 2890149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography.
    Graffner C; Lagerström PO; Lundborg P; Rönn O
    Br J Clin Pharmacol; 1979 Nov; 8(5):469-74. PubMed ID: 508553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cirrhosis of the liver on the pharmacokinetics of chlormethiazole.
    Pentikainen PJ; Neuvonen PJ; Tarpila S; Syvälahti E
    Br Med J; 1978 Sep; 2(6141):861-3. PubMed ID: 709096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced bioavailability of pethidine and pentazocine in patients with cirrhosis of the liver.
    Pond SM; Tong T; Benowitz NL; Jacob P
    Aust N Z J Med; 1980 Oct; 10(5):515-9. PubMed ID: 6937164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absolute bioavailability of metoclopramide given orally or by enema in patients with normal liver function or with cirrhosis of the liver.
    Hellstern A; Hellenbrecht D; Saller R; Gatzen M; Manus B; Achtert G; Brockmann P; Hausleiter HJ; Leuschner U
    Arzneimittelforschung; 1987 Jun; 37(6):733-6. PubMed ID: 3663273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioavailability and pharmacokinetics of metoclopramide in cattle.
    Jones RD; Mizinga KM; Thompson FN; Stuedemann JA; Bowen JM
    J Vet Pharmacol Ther; 1994 Apr; 17(2):141-7. PubMed ID: 8040934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of metoclopramide in goats.
    Huhn JC; Koritz GD; Nelson DR; Brown SA
    J Vet Pharmacol Ther; 1992 Mar; 15(1):19-27. PubMed ID: 1573702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose pharmacokinetics of metoclopramide.
    Ross-Lee LM; Eadie MJ; Hooper WD; Bochner F
    Eur J Clin Pharmacol; 1981; 20(6):465-71. PubMed ID: 7286058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability and pharmacokinetics of rectally administered metoclopramide.
    Vergin H; Krammer R; Nitsche V; Miczka M; Strobel K; Schimmel H
    Arzneimittelforschung; 1990 Jun; 40(6):679-83. PubMed ID: 2397004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of dimeticone and pepsin on the bioavailability of metoclopramide in healthy volunteers.
    do Nascimento DF; Silva Leite AL; de Moraes RA; Camarão GC; Bezerra FA; de Moraes MO; de Moraes ME
    Drug Res (Stuttg); 2014 Oct; 64(10):537-40. PubMed ID: 24504688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability and disposition of metoclopramide after single- and multiple-dose administration in diabetic patients with gastroparesis.
    O'Connell ME; Awni WM; Goodman M; Cass O; Melikian AP; Wright GJ; Matzke GR
    J Clin Pharmacol; 1987 Aug; 27(8):610-4. PubMed ID: 3655009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral pharmacokinetics and ascitic fluid penetration of pefloxacin in cirrhosis.
    Cardey J; Silvain C; Bouquet S; Breux JP; Becq-Giraudon B; Fourtillan JP; Beauchant M
    Eur J Clin Pharmacol; 1987; 33(5):469-72. PubMed ID: 3480805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and protein binding of cefpiramide in patients with alcoholic cirrhosis.
    Demotes-Mainard F; Vinçon G; Amouretti M; Dumas F; Necciari J; Kieffer G; Begaud B
    Clin Pharmacol Ther; 1991 Mar; 49(3):263-9. PubMed ID: 2007321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pefloxacin kinetics in cirrhosis.
    Danan G; Montay G; Cunci R; Erlinger S
    Clin Pharmacol Ther; 1985 Oct; 38(4):439-42. PubMed ID: 3862496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ranitidine disposition in severe hepatic cirrhosis.
    Gonzalez-Martin G; Paulos C; Veloso B; Chesta J; Novoa X; Arancibia A
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):139-42. PubMed ID: 3557740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of fluvoxamine maleate in patients with liver cirrhosis after single-dose oral administration.
    van Harten J; Duchier J; Devissaguet JP; van Bemmel P; de Vries MH; Raghoebar M
    Clin Pharmacokinet; 1993 Feb; 24(2):177-82. PubMed ID: 8453824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.